BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 155 filers reported holding BLUEBIRD BIO INC in Q2 2022. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,937 | -7.6% | 26,624 | 0.0% | 0.01% | -16.7% |
| Q2 2023 | $87,593 | -37.6% | 26,624 | -39.7% | 0.01% | -14.3% |
| Q1 2023 | $140,314 | -54.0% | 44,124 | 0.0% | 0.01% | -62.2% |
| Q4 2022 | $305,338 | +9.3% | 44,124 | 0.0% | 0.04% | +15.6% |
| Q3 2022 | $279,305 | +13.5% | 44,124 | -25.9% | 0.03% | +52.4% |
| Q2 2022 | $246,000 | -64.0% | 59,524 | -57.7% | 0.02% | -27.6% |
| Q1 2022 | $683,000 | -54.7% | 140,824 | -6.6% | 0.03% | -68.5% |
| Q4 2021 | $1,507,000 | -65.7% | 150,824 | -34.5% | 0.09% | -67.3% |
| Q3 2021 | $4,397,000 | -36.1% | 230,100 | +7.0% | 0.28% | -34.3% |
| Q2 2021 | $6,876,000 | -4.2% | 215,000 | -9.7% | 0.43% | -5.7% |
| Q1 2021 | $7,176,000 | +2993.1% | 238,000 | +18207.7% | 0.45% | +1094.7% |
| Q4 2017 | $232,000 | – | 1,300 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
| Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
| ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
| EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
| Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
| APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
| Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
| PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |